FY2026 EPS Estimate for HCA Healthcare Boosted by Analyst

HCA Healthcare, Inc. (NYSE:HCA) – Equities research analysts at Zacks Research lifted their FY2026 EPS estimates for HCA Healthcare in a report released on Wednesday, November 11th. Zacks Research analyst Team now anticipates that the company will earn $30.00 per share for the year, up from their prior estimate of $29.40. The consensus estimate for HCA Healthcare’s current full-year earnings is $30.15 per share. Zacks Research also issued estimates for HCA Healthcare’s Q4 2026 earnings at $8.04 EPS, Q1 2027 earnings at $7.36 EPS, Q2 2027 earnings at $7.63 EPS, Q3 2027 earnings at $7.35 EPS, Q4 2027 earnings at $8.53 EPS, FY2027 earnings at $30.87 EPS, Q1 2028 earnings at $8.06 EPS, Q2 2028 earnings at $8.16 EPS, Q3 2028 earnings at $8.66 EPS and FY2028 earnings at $33.98 EPS.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.96 earnings per share.

A number of other equities research analysts have also recently commented on the stock. KeyCorp raised their price target on shares of HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a report on Wednesday, October 28th. Robert W. Baird upped their price objective on shares of HCA Healthcare from $393.00 to $409.00 and gave the company a “neutral” rating in a report on Wednesday, October 28th. Weiss Ratings raised shares of HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Finally, TD Cowen boosted their target price on HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $480.13.

HCA Healthcare Stock Down 1.1%

NYSE:HCA opened at $500.59 on Friday. HCA Healthcare has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a fifty day moving average of $451.01 and a 200-day moving average of $445.95. The firm has a market capitalization of $104.57 billion, a P/E ratio of 16.59, a P/E/G ratio of 1.69 and a beta of 1.11.

Institutional Trading of HCA Healthcare

Institutional investors have recently made changes to their positions in the company. DiPaolo Financial Group Inc. bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $29,000. MidFirst Bank bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $28,000. Clearstead Trust LLC bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $29,000. Latitude Advisors LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC bought a new stake in HCA Healthcare during the second quarter worth $35,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael J. Schlosser sold 1,200 shares of the company’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares in the company, valued at approximately $713,779.95. This represents a 45.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Erica Rossitto sold 3,500 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the sale, the senior vice president directly owned 13,426 shares of the company’s stock, valued at $6,791,005.06. The trade was a 20.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 36,413 shares of company stock valued at $18,251,464 over the last ninety days. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s payout ratio is currently 10.34%.

Latest HCA Healthcare News

These are some of the HCA news items that stood out recently:

• Positive Sentiment: Some later-quarter forecasts also increased, including Q3 2027 EPS and Q1 and Q3 2028 EPS, indicating the revisions were not uniformly negative. Zacks estimate updates
• Neutral Sentiment: Overall, the forecast changes are mixed: Zacks’s FY2027 estimate is now $30.87, down from $31.27, while its FY2028 estimate is $33.98, down from $34.24. The balance of near- and longer-term revisions may temper the positive impact of the FY2026 increases. Zacks estimate updates
• Negative Sentiment: An HCA senior vice president sold $1.77 million in company stock. Insider sales can raise concern about executives’ views, although a sale alone does not establish a negative outlook. Insider selling article

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.